Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Solid Tumors × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 210 Carcinoma, Non-Small-Cell Lung 65 Carcinoma, Renal Cell 52 Neoplasm Metastasis 44 Neoplasms 38 Prostatic Neoplasms 31 Lung Neoplasms 26 Uveal Melanoma 25 Carcinoma, Hepatocellular 22 Pancreatic Neoplasms 21 Brain Neoplasms 20 Sarcoma 19 Colorectal Neoplasms 19 Breast Neoplasms 19 Skin Neoplasms 16 Kidney Neoplasms 16 Squamous Cell Carcinoma of Head and Neck 15 Small Cell Lung Carcinoma 15 Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 13 Ovarian Neoplasms 12 Uterine Cervical Neoplasms 11 Triple Negative Breast Neoplasms 11 Mesothelioma 11 Diabetes Mellitus, Insulin-Dependent, 12 11 Recurrence 10 Head and Neck Neoplasms 10 Glioblastoma 10 Stomach Neoplasms 9 Multiple Myeloma 9

Interventions

Injections 20 Carboplatin 15 Docetaxel 13 Bevacizumab 10 pembrolizumab 9 Paclitaxel 9 Cisplatin 7 durvalumab 6 Fluorouracil 6 tislelizumab 5 linifanib 5 Pemetrexed 5 Nivolumab 5 Leucovorin 5 trifluridine tipiracil drug combination 4 olaparib 4 Oxaliplatin 4 Irinotecan 4 Capecitabine 4 zimberelimab 3 toripalimab 3 talazoparib 3 sintilimab 3 fludarabine 3 depatuxizumab 3 atezolizumab 3 S 1 (combination) 3 Panobinostat 3 Itraconazole 3 Gemcitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03461952 2024-02-22

NIMBLe

Canadian Cancer Trials Group

Phase 2 Terminated

4 enrolled 4 charts

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡